News & Events

March 27, 2023

Can miRNA Biomarkers Be Used to Diagnose Autism at Birth?

New Systematic Review and Meta-Analysis Believe It’s a Possibility Previous research has indicated that microRNAs (miRNAs) are strongly associated with the development of autism spectrum disorder (ASD) and affect gene expression related to different neurological pathways involved in the disorder. MicroRNAs are a family of molecules that helps cells control the types and amounts of […]

March 23, 2023

CDC Reports: 1 in 36 American Children Have Autism

4% of Boys and 1% of Girls Aged 8 Years Now Have the Disorder The Centers for Disease Control and Prevention (CDC) has just released its latest prevalence rate estimates for autism spectrum disorder (ASD). The CDC reports that 1 in 36 or 2.8% of American 8-year-olds has an autism diagnosis. This rate is a […]

safeminds community shares
March 20, 2023

Community Shares | March 20th 2023

Findings from a new population-based cohort study do not support a causal relationship between maternal use of benzodiazepines or Z-drugs during pregnancy and preterm birth, small for gestational age, autism, or ADHD. However, the study concludes that clinicians and pregnant women should carefully balance the known risks associated with these drugs when treating anxiety and […]

March 20, 2023

FDA Approves DAYBUE (Trofinetide) to Treat Rett Syndrome

Medication Will Be Available for Patients Two Years of Age and Older in April Acadia Pharmaceuticals Inc. recently announced that their medication, DAYBUETM (trofinetide) has gained approval from the U.S. Food and Drug Administration (FDA). DAYBUE is now the first and only drug approved for treating Rett Syndrome. The company expects the medication to be […]

March 20, 2023

Is Severe Autism Measured Adequately?

New Commentary Believes there’s a Better Way to Measure How the Condition Impacts Life A new commentary featured in the journal, Autism Research, calls for a more effective way of measuring severe autism that details specifically how an individual’s autism severity level impacts their life. Autism severity is currently defined and measured based exclusively on […]

March 13, 2023

Community Shares | March 13th 2023

UC Davis MIND Institute researchers have confirmed that brain development in people with autism varies from people without the disorder. According to their new study, these differences are associated with genes involved in inflammation, immune system response, and neural transmissions. These variations begin in childhood and progress throughout the lifespan. The study identified 194 significantly […]

Show Buttons
Hide Buttons